EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study

Yeva Prysiazhniuk iD, Andres Server iD, Henning Leske iD, Øystein Bech-Aase, Eirik Helseth iD, Roelant Sjouke Eijgelaar iD, Elies Fuster-García iD, Petter Brandal iD, Atle Bjørnerud iD, Jakub Otáhal iD, Jan Petr iD, Wibeke Nordhøy iD

Neuro-Oncology Advances · 01.01.2024 · 6 (1)

DOI: 10.1093/noajnl/vdae113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 05.07.2024. Verfasst von Yeva Prysiazhniuk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, The Czech Republic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Health Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluation of molecular markers (IDH, pTERT, 1p/19q codeletion, and MGMT) in adult diffuse gliomas is crucial for accurate diagnosis and optimal treatment planning. Dynamic Susceptibility Contrast (DSC) and Arterial Spin Labeling (ASL) perfusion MRI techniques have both shown good performance in classifying molecular markers, however, their performance has not been compared side-by-side.

Methods

Pretreatment MRI data from 90 patients diagnosed with diffuse glioma (54 men/36 female, 53.1 ± 15.5 years, grades 2–4) were retrospectively analyzed. DSC-derived normalized cerebral blood flow/volume (nCBF/nCBV) and ASL-derived nCBF in tumor and perifocal edema were analyzed in patients with available IDH-mutation (n = 67), pTERT-mutation (n = 39), 1p/19q codeletion (n = 33), and MGMT promoter methylation (n = 31) status. Cross-validated uni- and multivariate logistic regression models assessed perfusion parameters’ performance in molecular marker detection.

Results

ASL and DSC perfusion parameters in tumor and edema distinguished IDH-wildtype (wt) and pTERT-wt tumors from mutated ones. Univariate classification performance was comparable for ASL-nCBF and DSC-nCBV in IDH (maximum AUROCC 0.82 and 0.83, respectively) and pTERT (maximum AUROCC 0.70 and 0.81, respectively) status differentiation. The multivariate approach improved IDH (DSC-nCBV AUROCC 0.89) and pTERT (ASL-nCBF AUROCC 0.8 and DSC-nCBV AUROCC 0.86) classification. However, ASL and DSC parameters could not differentiate 1p/19q codeletion or MGMT promoter methylation status. Positive correlations were found between ASL-nCBF and DSC-nCBV/-nCBF in tumor and edema.

Conclusions

ASL is a viable gadolinium-free replacement for DSC for molecular characterization of adult diffuse gliomas.

Schlagwörter

Stichwörter der Autor:innen

ASLDSCIDHgliomapTERT

Autor:innen und Institutionen

  • Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, The Czech Republic.
  • Section of Neuroradiology, Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

ORCID-Profile: Yeva Prysiazhniuk, Andres Server, Henning Leske, Eirik Helseth, Roelant Sjouke Eijgelaar, Elies Fuster-García, Petter Brandal, Atle Bjørnerud, Jakub Otáhal, Jan Petr, Wibeke Nordhøy

Förderung

  • Czech Health Research Council

Zitieren

APA

Prysiazhniuk, Y., Server, A., Leske, H., Bech-Aase, Ø., Helseth, E., Eijgelaar, R. S., Fuster-García, E., Brandal, P., Bjørnerud, A., Otáhal, J., Petr, J., & Nordhøy, W. (2024). Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study. Neuro-Oncology Advances, 6(1). https://doi.org/10.1093/noajnl/vdae113

Vancouver

Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, et al. Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study. Neuro-Oncology Advances. 2024;6(1). doi:10.1093/noajnl/vdae113

BibTeX
@article{Prysiazhniuk2024,
  author = {Prysiazhniuk, Yeva and Server, Andres and Leske, Henning and Bech-Aase, Øystein and Helseth, Eirik and Eijgelaar, Roelant Sjouke and Fuster-García, Elies and Brandal, Petter and Bjørnerud, Atle and Otáhal, Jakub and Petr, Jan and Nordhøy, Wibeke},
  title = {Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study},
  journal = {Neuro-Oncology Advances},
  year = {2024},
  volume = {6},
  number = {1},
  doi = {10.1093/noajnl/vdae113}
}
Kostenlos starten →